Doxazosin Mesylate is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads 77883-43-3. It is used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia - BPH. Detailed specification, Certificate of Analysis and samples are available on request.

Pharmaceuticals – import-export
  • API
  • antihypertensive
  • Doxazosin Mesylate

Product features

CAS 77883-43-3
Product Information API
Route of Synthesis Synthetic
Patent Expiry EU, US - expired
Indication Antihypertensive, Adrenergic Blocker
Dosage Oral formulation

Need more information from the seller?

Share on: